» Articles » PMID: 20375117

Transgenic Overexpression of GLUT1 in Mouse Glomeruli Produces Renal Disease Resembling Diabetic Glomerulosclerosis

Overview
Specialties Nephrology
Physiology
Date 2010 Apr 9
PMID 20375117
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Previous work identified an important role for hyperglycemia in diabetic nephropathy (The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986, 1993; UK Prospective Diabetes Study Group. Lancet 352: 837-853, 1998), and increased glomerular GLUT1 has been implicated. However, the roles of GLUT1 and intracellular glucose have not been determined. Here, we developed transgenic GLUT1-overexpressing mice (GT1S) to characterize the roles of GLUT1 and intracellular glucose in the development of glomerular disease without diabetes. GLUT1 was overexpressed in glomerular mesangial cells (MC) of C57BL6 mice, a line relatively resistant to diabetic nephropathy. Blood pressure, blood glucose, glomerular morphometry, matrix proteins, cell signaling, transcription factors, and selected growth factors were examined. Kidneys of GT1S mice overexpressed GLUT1 in glomerular MCs and small vessels, rather than renal tubules. GT1S mice were neither diabetic nor hypertensive. Glomerular GLUT1, glucose uptake, mean capillary diameter, and mean glomerular volume were all increased in the GT1S mice. Moderately severe glomerulosclerosis (GS) was established by 26 wk of age in GT1S mice, with increased glomerular type IV collagen and fibronectin. Modest increases in glomerular basement membrane thickness and albuminuria were detected with podocyte foot processes largely preserved, in the absence of podocyte GLUT1 overexpression. Activation of glomerular PKC, along with increased transforming growth factor-beta1, VEGFR1, VEGFR2, and VEGF were all detected in glomeruli of GT1S mice, likely contributing to GS. The transcription factor NF-kappaB was also activated. Overexpression of glomerular GLUT1, mimicking the diabetic GLUT1 response, produced numerous features typical of diabetic glomerular disease, without diabetes or hypertension. This suggested GLUT1 may play an important role in the development of diabetic GS.

Citing Articles

Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy.

Liu S, Zhao Y, Lu S, Zhang T, Lindenmeyer M, Nair V Genome Med. 2023; 15(1):2.

PMID: 36627643 PMC: 9830686. DOI: 10.1186/s13073-022-01145-4.


Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis.

Wei X, Hou Y, Long M, Jiang L, Du Y Front Endocrinol (Lausanne). 2022; 13:927329.

PMID: 35957825 PMC: 9357883. DOI: 10.3389/fendo.2022.927329.


Revisiting Experimental Models of Diabetic Nephropathy.

Giralt-Lopez A, Molina-Van den Bosch M, Vergara A, Garcia-Carro C, Seron D, Jacobs-Cacha C Int J Mol Sci. 2020; 21(10).

PMID: 32438732 PMC: 7278948. DOI: 10.3390/ijms21103587.


Ion channels and transporters in diabetic kidney disease.

Spires D, Manis A, Staruschenko A Curr Top Membr. 2019; 83:353-396.

PMID: 31196609 PMC: 6815098. DOI: 10.1016/bs.ctm.2019.01.001.


Treatment Shows Protective Effects on Renal Injury and Metabolic Modulation in db/db Mice.

Lu Z, Li S, Sun R, Jia X, Xu C, Aa J Evid Based Complement Alternat Med. 2019; 2019:4732858.

PMID: 31080482 PMC: 6475559. DOI: 10.1155/2019/4732858.


References
1.
Studer R, Craven P, Derubertis F . Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes. 1993; 42(1):118-26. DOI: 10.2337/diab.42.1.118. View

2.
. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

3.
Schrijvers B, Flyvbjerg A, De Vriese A . The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004; 65(6):2003-17. DOI: 10.1111/j.1523-1755.2004.00621.x. View

4.
Derubertis F, Craven P . Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes. 1994; 43(1):1-8. DOI: 10.2337/diab.43.1.1. View

5.
Sakai T, Kriz W . The structural relationship between mesangial cells and basement membrane of the renal glomerulus. Anat Embryol (Berl). 1987; 176(3):373-86. DOI: 10.1007/BF00310191. View